The HRT Index · Research & Reference
An independent research library for menopause and hormone therapy
This is the reference section of The HRT Index — a set of verified, plainly sourced data assets on menopause hormone therapy and its alternatives. Each entry is dated and maintained as a public reference. It is deliberately kept separate from the rest of the site: no products, no promotions, nothing to sign up for. Just the facts, organized to be cited.
Reference assets
- Economic data
Cost of Menopause in the U.S. (2026)
A source-traced explanation of the $5.4B, $24.8B, and $26.6B figures, plus state, industry, personal, insurance, and treatment-cost evidence.
- Data report
How Many Women Use HRT? 2026 Statistics
Seven source-specific HRT utilization datasets from FDA, NHANES, Epic, Truveta, NHSBSA, and more — with every denominator, definition, and limitation preserved.
- Workplace statistics
Menopause Workplace Statistics 2026
A denominator-first audit of U.S. menopause work impact, productivity loss, employer support, communication gaps, workplace law, and 27 verified facts.
- HRT prescribing data
HRT Prescribing Trends 2026
A dated audit of U.S. HRT prescribing, route shifts, FDA label changes, shortages, access gaps, and what utilization datasets cannot prove.
- Access data
Menopause Care Deserts by State: 2024 Data
A reproducible 50-state comparison of Menopause Society Certified Practitioner density, bottom-quartile access deserts, source methods, and downloadable data.
- Market data
Menopause Market Size 2026: Data & Forecast
A dated audit of public menopause market-size estimates, normalized benchmarks, scope differences, CAGR checks, company reporting, and a downloadable source ledger.
- Funding data
Menopause Startup Funding Data 2026
A source-backed ledger of 14 disclosed financing events across six U.S. menopause-specialist clinical-care companies, with reconciliation tables and a downloadable CSV.
- Clinical research history
Women's Health Initiative Timeline
A source-normalized WHI chronology separating program milestones, intervention stops, long-term findings, funding, FDA actions, and the primary records behind every date.
- Statistics data
Hot Flash Statistics 2026
The Hot Flash Statistics Evidence Atlas: pooled prevalence, timing, daily frequency, episode length, duration, thresholds, treatment populations, and downloads.
- EHR data
Menopause Diagnosis Statistics 2026
11 metrics from 10 U.S. source families — PCORnet 9.6% EHR benchmark, age-specific rates, ADI quartile rates, and N95 code-scope bounds.
- Medical education data
Menopause Medical Education Statistics
68-row evidence audit — 2022 program-director survey, 2017 preparedness data, 9-document standards-language audit, and 2026 NIH and federal-legislation snapshot.
- Disparities data
Menopause Racial Disparities 2026
Nine primary U.S. studies, 66 evidence rows — VMS duration 55% longer, 0.5% vs 5.8% MHT use, VA prescribing gaps, and the full insurance analysis.
- Statistics data
Menopause Statistics 2026
A source-traced menopause statistics ledger: 19 symptom rates, stage comparisons, age, duration, work, treatment, POI, denominator corrections, and downloads.
- Economic data
Menopause Workplace Cost: 2026 U.S. Data
RAND $5.4B model reproduced to $0.40 — component shares, per-worker coefficients, full state and industry tables, and cost-bearer map.
- Employer data
Companies With Menopause Benefits: 2026
40 employers coded across clinical access, HRT support, leave, adjustments, education and formal policy — every row links to employer-controlled evidence.
- Supply tracker
HRT Shortage Tracker 2026: FDA vs ASHP Data
Same-day FDA and ASHP reconciliation for U.S. menopause HRT product groups — estradiol patches, progesterone capsules, and vaginal cream — with downloadable data.
- Statute tracker
Menopause Laws by State: 2026 Tracker
50-state audit of enacted menopause-specific statutes as of July 31, 2026 — with official bill numbers, effective dates, coverage scope, and downloadable data.
- Federal funding data
Menopause Research Funding: NIH 2007-2025
Two federal reporting systems, sixteen fiscal years, and the arithmetic behind every circulating total — including the $617M and $701.773M figures.
- Statute tracker
Menopause Workplace Laws by State: 2026
51-jurisdiction audit of enacted menopause workplace accommodation laws, pending bills, executive actions, and vetoed measures — with downloadable data.
- Tracker
Estradiol Patch Shortage Tracker 2026
FDA says no shortage; ASHP lists 14 twice-weekly patches backordered. Full breakdown by manufacturer, strength, and NDC — sourced and dated.
- Tracker
FDA HRT Label Change Tracker 2026
Six HRT products have FDA-approved updated labels. Full label-by-label breakdown: which boxed warnings were removed, which were kept, with FDA Reference IDs.
- Data table
FDA-Approved HRT Reference
Every FDA-approved category of menopause hormone therapy, organized by route and drug class in one scannable table.
- Data table
FDA-Approved vs Compounded HRT Providers
What 12 online HRT services publicly say about FDA-approved vs compounded hormone pathways — a primary-sourced July 2026 ledger.
- Reference
Menopause & HRT Glossary
Plain-language definitions for the menopause and hormone-therapy terms that show up in research, labels, and clinic visits.
- Data table
Nonhormonal Hot Flash Reference
FDA-approved and off-label nonhormonal treatments for hot flashes, with drug class, approval status, and key monitoring in one place.
About this section
How the research library works
Every asset here is built from primary sources — FDA prescribing labels, regulatory notices, and peer-reviewed literature — and carries a visible “last updated” date. We revisit each reference on a regular schedule and revise it when the underlying facts change. Nothing in this section is sponsored, and nothing links out to a product or a paid placement. If you spot something that needs correcting, that is exactly the kind of note we want.
Reference material only. This library is not medical advice and does not replace a consultation with a licensed clinician.